247 related articles for article (PubMed ID: 17695420)
21. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
22. Urinary levels of cyclic guanosine monophosphate (cGMP) in patients with cancer of the uterine cervix: a valuable prognostic factor of clinical outcome?
Orbo A; Jaeger R; Sager G
Eur J Cancer; 1998 Aug; 34(9):1460-2. PubMed ID: 9849432
[TBL] [Abstract][Full Text] [Related]
23. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers.
Hiramatsu K; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H; Tanaka S; Tanaka C; Tamamori Y; Imajo M; Kawaguchi M; Toi M; Mori T; Kawakita M
Clin Cancer Res; 2005 Apr; 11(8):2986-90. PubMed ID: 15837752
[TBL] [Abstract][Full Text] [Related]
24. Tissue polypeptide specific antigen (TPS) and carbohydrate antigen 125 (CA-125) in the early prediction of recurrent ovarian cancer.
Yeh LS; Hung YC; Kao A; Lin CC; Lee CC
Anticancer Res; 2002; 22(6B):3669-71. PubMed ID: 12552974
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of pretherapeutic tetranectin and CA-125 in patients with relapse of ovarian cancer.
Deng X; Høgdall EV; Høgdall CK; Nørgaard-Pedersen B; Jørgensen M; Nielsen H; Engelholm SA
Gynecol Oncol; 2000 Dec; 79(3):416-9. PubMed ID: 11104612
[TBL] [Abstract][Full Text] [Related]
26. Urinary gonadotropin peptide (UGP) as a marker of gynecologic malignancies.
Walker R; Crebbin V; Stern J; Scudder S; Schwartz P
Anticancer Res; 1994; 14(5A):1703-9. PubMed ID: 7847804
[TBL] [Abstract][Full Text] [Related]
27. Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range.
Santillan A; Garg R; Zahurak ML; Gardner GJ; Giuntoli RL; Armstrong DK; Bristow RE
J Clin Oncol; 2005 Dec; 23(36):9338-43. PubMed ID: 16361633
[TBL] [Abstract][Full Text] [Related]
28. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
[TBL] [Abstract][Full Text] [Related]
29. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
[TBL] [Abstract][Full Text] [Related]
30. Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance.
Sier CF; Sidenius N; Mariani A; Aletti G; Agape V; Ferrari A; Casetta G; Stephens RW; Brünner N; Blasi F
Lab Invest; 1999 Jun; 79(6):717-22. PubMed ID: 10378514
[TBL] [Abstract][Full Text] [Related]
31. [Cyclic GMP as a biomarker for cardiovascular disease and cancer].
Ulvestad L; Sager G
Tidsskr Nor Laegeforen; 2005 Jan; 125(1):27-8. PubMed ID: 15643459
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-6/10 ratio as a prognostic marker of recurrence in patients with intermediate risk urothelial bladder carcinoma.
Cai T; Mazzoli S; Meacci F; Tinacci G; Nesi G; Zini E; Bartoletti R
J Urol; 2007 Nov; 178(5):1906-11;discussion 1911-2. PubMed ID: 17868727
[TBL] [Abstract][Full Text] [Related]
33. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of different serum tumor markers in gynecological malignancies.
Paulick R; Caffier H; Horner G; Lang K; Filbry E
Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031
[TBL] [Abstract][Full Text] [Related]
35. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
[TBL] [Abstract][Full Text] [Related]
36. [The value of determination of urine cAMP and cGMP in the diagnosis and predicting the therapeutic effect of malignant ovarian tumors].
Wu XH; Zhang JG
Zhonghua Fu Chan Ke Za Zhi; 1991 May; 26(3):162-5, 188. PubMed ID: 1651834
[TBL] [Abstract][Full Text] [Related]
37. Urinary endothelin in glomerulonephritis patients with normal renal function.
Roccatello D; Mosso R; Ferro M; Polloni R; De Filippi PG; Quattrocchio G; Bancale E; Cesano G; Sena LM; Piccoli G
Clin Nephrol; 1994 Jun; 41(6):323-30. PubMed ID: 8076434
[TBL] [Abstract][Full Text] [Related]
38. [The significance of urine di-acetyl spermine level as a cancer marker for colorectal cancer].
Takahashi K; Hiramatsu K; Kawakita M; Mori T; Yamaguchi T; Matsumoto H; Miyamoto H; Tamamori Y
Rinsho Byori; 2004 Apr; 52(4):332-5. PubMed ID: 15164601
[TBL] [Abstract][Full Text] [Related]
39. Can the levels of nitric oxide in the urine, serum and tumor tissue be putative markers for bladder cancer?
Kiliç S; Bayraktar N; Beytur A; Ergin H; Bayraktar M; Egri M
Int J Urol; 2006 Aug; 13(8):1079-85. PubMed ID: 16903933
[TBL] [Abstract][Full Text] [Related]
40. Urinary cyclic guanosine 3',5'-monophosphate and cyclic adenosine 3',5'-monophosphate changes in spontaneous and induced onset active labor.
Chen DC; Yuan SS; Su HY; Lo SC; Ren SS; Wu GJ
Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1081-6. PubMed ID: 16232176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
